Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics has announced promising preclinical results for its lead drug ...

Amgen (AMGN) announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of ...

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug Nuvectis Pharma, Inc. (NASDAQ: NVCT) stock is trading lower after the company reported ...

While not powered for statistical efficacy, the study showed promising trends favoring topical pravibismane plus standard of care (SoC) evaluating exploratory efficacy endpoints including complete ...

Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

A drug-eluting contact lens that uses 3D printing technology can improve IOP and treatment compliance for patients with glaucoma.

College students have opportunities to bend or break the rules after leaving home. It can be dangerous for those who take ...

For decades, the medical world has avidly searched for groundbreaking treatments against one of humanity’s most resilient ...

In-vivo CRO market size is projected to reach over USD 9 billion in revenue by the end of 2032. The demand for in vivo CROs ...

Recently approved xanomeline and trospium chloride (Cobenfy) demonstrated long-term efficacy and safety in patients with ...

Investigators from the LIFE-BTK randomized controlled trial evaluating the use of the Drug-Eluting Resorbable Scaffold (Abbott) ...

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all ...